These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 24445279)

  • 21. Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation.
    Luo Y; Guo Y; Wang H; Yu M; Hong K; Li D; Li R; Wen B; Hu D; Chang L; Zhang J; Yang B; Sun D; Schwendeman AS; Eugene Chen Y
    EBioMedicine; 2021 Dec; 74():103725. PubMed ID: 34879325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Atorvastatin inhibits the atherosclerotic lesion induced by tumor necrosis factor-like weak inducer of apoptosis in apolipoprotein E deficient mice].
    Fernández-Laso V; Sastre C; Egido J; Martín-Ventura JL; Blanco-Colio LM
    Clin Investig Arterioscler; 2015; 27(1):17-25. PubMed ID: 25027757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ganglioside GM3-Functionalized Reconstituted High-Density Lipoprotein (GM3-rHDL) as a Novel Nanocarrier Enhances Antiatherosclerotic Efficacy of Statins in apoE
    Wei B; Li Y; Ao M; Shao W; Wang K; Rong T; Zhou Y; Chen Y
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization.
    Stoll G; Bendszus M
    Stroke; 2006 Jul; 37(7):1923-32. PubMed ID: 16741184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Everolimus-Loaded Reconstituted High-Density Lipoprotein Prepared by a Novel Dual Centrifugation Approach for Anti-Atherosclerotic Therapy.
    Deuringer B; Härdtner C; Krebs K; Thomann R; Holzer M; Hilgendorf I; Süss R
    Int J Nanomedicine; 2022; 17():5081-5097. PubMed ID: 36340183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins Disrupt Macrophage Rac1 Regulation Leading to Increased Atherosclerotic Plaque Calcification.
    Healy A; Berus JM; Christensen JL; Lee C; Mantsounga C; Dong W; Watts JP; Assali M; Ceneri N; Nilson R; Neverson J; Wu WC; Choudhary G; Morrison AR
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):714-732. PubMed ID: 31996022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE-/- Mice: Evidence of ABCA1 Down-Regulation.
    Tardy C; Goffinet M; Boubekeur N; Cholez G; Ackermann R; Sy G; Keyserling C; Lalwani N; Paolini JF; Dasseux JL; Barbaras R; Baron R
    PLoS One; 2015; 10(9):e0137584. PubMed ID: 26335690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the Combined Effect of Recombinant High-Density Lipoprotein Carrier and the Encapsulated Lovastatin in RAW264.7 Macrophage Cells Based on the Median-Effect Principle.
    Jiang C; Zhao Y; Yang Y; He J; Zhang W; Liu J
    Mol Pharm; 2018 Mar; 15(3):1017-1027. PubMed ID: 29382194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
    Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supramolecular copolymer modified statin-loaded discoidal rHDLs for atherosclerotic anti-inflammatory therapy by cholesterol efflux and M2 macrophage polarization.
    Zhang Q; He J; Xu F; Huang X; Wang Y; Zhang W; Liu J
    Biomater Sci; 2021 Sep; 9(18):6153-6168. PubMed ID: 34346410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice.
    Yin M; Liu Q; Yu L; Yang Y; Lu M; Wang H; Luo D; Rong X; Tang F; Guo J
    J Vasc Res; 2017; 54(3):123-130. PubMed ID: 28448973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy.
    Verhoeven BA; Moll FL; Koekkoek JA; van der Wal AC; de Kleijn DP; de Vries JP; Verheijen JH; Velema E; Busser E; Schoneveld A; Virmani R; Pasterkamp G
    Stroke; 2006 Aug; 37(8):2054-60. PubMed ID: 16809559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual-probe molecular MRI for the in vivo characterization of atherosclerosis in a mouse model: Simultaneous assessment of plaque inflammation and extracellular-matrix remodeling.
    Reimann C; Brangsch J; Kaufmann JO; Adams LC; Onthank DC; Thöne-Reineke C; Robinson SP; Hamm B; Botnar RM; Makowski MR
    Sci Rep; 2019 Sep; 9(1):13827. PubMed ID: 31554825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A reconstituted HDL containing V156K or R173C apoA-I exhibited anti-inflammatory activity in apo-E deficient mice and showed resistance to myeloperoxidase-mediated oxidation.
    Cho KH; Kim JR
    Exp Mol Med; 2009 Jun; 41(6):417-28. PubMed ID: 19322022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statin prevents plaque disruption in apoE-knockout mouse model through pleiotropic effect on acute inflammation.
    Nakamura K; Sasaki T; Cheng XW; Iguchi A; Sato K; Kuzuya M
    Atherosclerosis; 2009 Oct; 206(2):355-61. PubMed ID: 19296953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE
    Song Y; Huang Z; Liu X; Pang Z; Chen J; Yang H; Zhang N; Cao Z; Liu M; Cao J; Li C; Yang X; Gong H; Qian J; Ge J
    Nanomedicine; 2019 Jan; 15(1):13-24. PubMed ID: 30171903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of Fatty Acid Modification on Uptake of Lovastatin-Loaded Reconstituted High Density Lipoprotein by Foam Cells.
    Yang Y; Wang J; He H; Zhang W; Zhang Y; Liu J
    Pharm Res; 2018 May; 35(7):134. PubMed ID: 29736804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tanshinone IIA-loaded reconstituted high density lipoproteins: Atherosclerotic plaque targeting mechanism in a foam cell model and pharmacokinetics in rabbits.
    Zhang W; Li J; Liu J; Wu Z; Xu Y; Wang J
    Pharmazie; 2012 Apr; 67(4):324-30. PubMed ID: 22570939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure and remodeling behavior of drug-loaded high density lipoproteins and their atherosclerotic plaque targeting mechanism in foam cell model.
    Zhang WL; Xiao Y; Liu JP; Wu ZM; Gu X; Xu YM; Lu H
    Int J Pharm; 2011 Oct; 419(1-2):314-21. PubMed ID: 21835236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.